You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 26, 2024

AMOXAPINE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Amoxapine patents expire, and when can generic versions of Amoxapine launch?

Amoxapine is a drug marketed by Chartwell Rx, Watson Labs, and Watson Pharms Teva. and is included in nine NDAs.

The generic ingredient in AMOXAPINE is amoxapine. There are four drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the amoxapine profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Amoxapine

A generic version of AMOXAPINE was approved as amoxapine by WATSON LABS on August 28th, 1992.

  Try a Trial

Drug patent expirations by year for AMOXAPINE
Drug Prices for AMOXAPINE

See drug prices for AMOXAPINE

Recent Clinical Trials for AMOXAPINE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Federal University of São PauloPhase 4
Fundação de Amparo à Pesquisa do Estado de São PauloPhase 4
Alexza Pharmaceuticals, Inc.Phase 1

See all AMOXAPINE clinical trials

Pharmacology for AMOXAPINE
Anatomical Therapeutic Chemical (ATC) Classes for AMOXAPINE

US Patents and Regulatory Information for AMOXAPINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Chartwell Rx AMOXAPINE amoxapine TABLET;ORAL 072943-001 Jun 28, 1991 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Watson Labs AMOXAPINE amoxapine TABLET;ORAL 072691-004 Aug 28, 1992 RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Chartwell Rx AMOXAPINE amoxapine TABLET;ORAL 072879-001 Jun 28, 1991 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Watson Pharms Teva AMOXAPINE amoxapine TABLET;ORAL 072421-001 May 11, 1989 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.